About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,533
By Phase
PHASE1/PHASE2: 2PHASE3: 3PHASE1: 4
By Status
COMPLETED: 4RECRUITING: 2NOT_YET_RECRUITING: 1UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06757335Lead Sponsor
A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer
PHASE1/PHASE2Not yet recruiting
204 participants
Started: Jan 7, 2025 · Completed: Nov 27, 2026
NCT06155084Lead Sponsor
A Phase I/II Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients
PHASE1/PHASE2Recruiting
84 participants
Started: Dec 26, 2023 · Completed: Sep 30, 2026
NCT04986176Collaborator
HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients
PHASE3Unknown
602 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2022
NCT05252364Lead Sponsor
A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE1Completed
22 participants
Started: Dec 14, 2021 · Completed: Jan 22, 2024
NCT03850795Lead Sponsor
HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
PHASE3Terminated
104 participants
Started: Mar 15, 2021 · Completed: Jun 28, 2024
Locations (1)
Headquarters
Chengdu, China
Map
Loading map...